OANDP-L
  • Login
No Result
View All Result
The O&P EDGE
  • PECOS
  • Magazine
    • Subscription
    • Current Issue
    • Issue Archive
    • News Archive
    • Product & Service Directory
    • Advertising Information
    • EDGE Flipbooks
  • O&P Jobs
    • Find a Job
    • Post a Job
  • EDGE Advantage
    • EA Homepage
    • EA Data
  • O&P Facilities
  • Resources
    • Product & Service Directory
    • Calendar
    • Contact
    • About Us
    • O&P Library
    • The Guide
    • Custom Publications
    • Advertising Information
    • EDGE Direct
    • Amplitude Media Group
  • PECOS
  • Magazine
    • Subscription
    • Current Issue
    • Issue Archive
    • News Archive
    • Product & Service Directory
    • Advertising Information
    • EDGE Flipbooks
  • O&P Jobs
    • Find a Job
    • Post a Job
  • EDGE Advantage
    • EA Homepage
    • EA Data
  • O&P Facilities
  • Resources
    • Product & Service Directory
    • Calendar
    • Contact
    • About Us
    • O&P Library
    • The Guide
    • Custom Publications
    • Advertising Information
    • EDGE Direct
    • Amplitude Media Group
No Result
View All Result
The O&P EDGE Magazine
No Result
View All Result
Home News

Gene Implicated in Phantom Pain Amputees Experience

by The O&P EDGE
October 24, 2011
in News
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

A novel gene that animal and human studies have implicated in the genetics of neuropathic pain-which could also prove to be promising for amputees who experience phantom pain-has been identified and validated by Israeli researchers. Their study was presented during the 12th International Congress of Human Genetics and the 61st American Society of Human Genetics Annual Meeting October 12, in Montreal, Quebec, Canada.

Jonathan Nissenbaum, PhD, from Hebrew University, Jerusalem, Israel, and colleagues used an integrative whole-genome-based approach to narrow down several hundred potential candidate genes, without an a priori assumption of the identity of the gene, to a single gene, the CACNG2 gene, that is implicated in pain behaviors in mice. The CACNG2 gene is a calcium-channel, voltage-dependent gamma subunit 2 that encodes for a protein known as “stargazin.”

In an interview with Medscape Medical News, Dr. Nissenbaum said it was “interesting” to investigate pain from a genetic perspective and to provide a physiologic basis for which amputees are predisposed to develop phantom limb pain.

“These patients complain about terrible pain and, even from a philosophical point of view, it’s difficult to accept that an organ that…does not exist produces pain, and that these patients are suffering,” he said. These findings could “legitimize” phantom limb pain by identifying a gene that makes individuals susceptible to that pain, he said.

Ultimately, the hope is that a new neuropathic pain treatment will emerge based on the biology of the implicated gene and the protein it encodes. Session moderator Inna Belfer, MD, PhD, associate professor of anesthesiology and human genetics at the University of Pittsburg (Pitt), Pennsylvania, told Medscape Medical News that the Israeli research was “promising,” in that they had “multiple lines of evidence leading to the gene.”

The research was also conducted on animals and humans, so the gene is a good target, she added. “What we are trying to do with our genetic studies is identify those at risk of developing neuropathic pain; for example, to identify new molecules and new pathways that are involved in a certain condition, such as neuropathic pain, and to prioritize those targets and pathways so we can narrow our focus down to a specific pathway. Once we have the gene, we can move on to the biology of the gene, and from there to regimens that modulate the function of the biology and correct the problem.”

In a subsequent cohort of 549 post-mastectomy patients with phantom breast pain identified by researchers in Toronto, Ontario, Canada, the same gene was identified and correlated to the genotype and the phenotype of each patient.

This correlation was based on selected single-nucleotide polymorphisms (SNPs) covering the regulatory and coding regions of the human CACNG2 gene, which were compared in DNA samples from women with and without post-mastectomy neuropathic pain.

On association analyses, “we found 3 SNP haplotypes that were associated with the tendency to develop neuropathic pain. Since it was marginally significant, further verification with a much larger cohort is needed,” Dr. Nissenbaum observed.

The researchers used a combination of methodologies to reduce the number of genes to a “manageable list” of about 10 or fewer, all of which could be relatively easily assessed for their potential properties.

“According to the criteria we set, we found only one gene that met all of our criteria,” Dr. Nissenbaum said, though it took many steps and more than a few years to identify.
Researchers are still presently making assumptions about the gene based on what they know about the protein encoded by CACNG2. For example, they know that the gene encodes for a neurologic protein known as stargazin, which is associated with recurrent epileptic seizures, ataxia, and neuropathic pain in mice.

“We know that most, if not all, good neuropathic pain drugs were developed or function as anticonvulsant drugs, so we have a link between these two entities (i.e., neuropathic pain and epilepsy),” Dr. Nissenbaum said.

Stargazin is exclusively expressed in the peripheral and the central nervous system; there is no evidence from the literature suggesting that it is expressed in any other tissue. The protein also has two major functions that might be relevant to pain-it is a voltage-sensitive calcium-channel subunit and it is involved in trafficking AMPA receptors (receptors for glutamate) to neuronal membranes.

“Both functions affect neuronal excitability, hence, they are relevant to pain,” Dr. Nissenbaum noted.

Related posts:

  1. Phantom Pain Is No Phantom
  2. Losses Beyond the Limb
  3. Understanding and Managing Chronic Pain in the Traumatic Amputee
  4. Examining the Uses of Virtual Reality in Prosthetic Rehabilitation
Previous Post

Study Reveals High Cost of PAD-Related Amputations

Next Post

Breast Cancer Survivor Creates Prosthesis ID Card for Travelers

Next Post

Breast Cancer Survivor Creates Prosthesis ID Card for Travelers

Linkedin X-twitter Facebook

VIEW CURRENT ISSUE

SUBSCRIBE FOR FREE

 

RECENT NEWS

Get unlimited access!

Join EDGE ADVANTAGE and unlock The O&P EDGE's vast library of archived content.
SUBSCRIBE TODAY

O&P JOBS

Pacific

Pediatric Orthotic & Prosthetic Clinician Department of Orthopaedic Surgery – UCSF

Eastern

CERTIFIED ORTHOTIC FITTER

Canada

Certified Orthotist & Orthotic Technician

The O&P EDGE Magazine
 
Required 'Candidate' login to applying this job. Click here to logout And try again
 

Login to your account

  • Forgot Password? | Sign Up

Reset Password

  • Already have an account? Login

Enter the username or e-mail you used in your profile. A password reset link will be sent to you by email.

Signup to your Account

  • By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

    Already have an account? Login

Close
No Result
View All Result
  • PECOS
  • MAGAZINE
    • SUBSCRIBE
    • CURRENT ISSUE
    • ISSUE ARCHIVE
    • NEWS ARCHIVE
    • PRODUCTS & SERVICES DIRECTORY
    • ADVERTISING INFORMATION
  • O&P JOBS
    • FIND A JOB
    • POST A JOB
  • EDGE ADVANTAGE
    • EA Homepage
    • EA Data
  • FACILITIES
  • RESOURCES
    • PRODUCTS & SERVICES DIRECTORY
    • CALENDAR
    • CONTACT
    • ABOUT US
    • O&P LIBRARY
    • THE GUIDE
    • CUSTOM PUBLICATIONS
    • ADVERTISING INFORMATION
    • EDGE DIRECT
    • AMPLITUDE
  • OANDP-L
  • LOGIN

© 2025 The O&P EDGE

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
 

Account Activation

Before you can login, you must activate your account with the code sent to your email address. If you did not receive this email, please check your junk/spam folder. Click here to resend the activation email. If you entered an incorrect email address, you will need to re-register with the correct email address.

 

© 2024 The O&P EDGE

  • About
  • Advertise
  • Contact
  • EDGE Advantage
  • OANDP-L
  • Subscribe

CONTACT US

866-613-0257

[email protected]

201 E. 4th St.
Loveland, CO 80537

The most important industry news and events delivered directly to your inbox every week.

  • About
  • Advertise
  • Contact
  • EDGE Advantage
  • OANDP-L
  • Subscribe

© 2025 The O&P EDGE

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
The O&P EDGE Magazine
 
Required 'Candidate' login to applying this job. Click here to logout And try again
 

Login to your account

  • Forgot Password? | Sign Up

Reset Password

  • Already have an account? Login

Enter the username or e-mail you used in your profile. A password reset link will be sent to you by email.

Signup to your Account

  • By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

    Already have an account? Login

Close
No Result
View All Result
  • PECOS
  • MAGAZINE
    • SUBSCRIBE
    • CURRENT ISSUE
    • ISSUE ARCHIVE
    • NEWS ARCHIVE
    • PRODUCTS & SERVICES DIRECTORY
    • ADVERTISING INFORMATION
  • O&P JOBS
    • FIND A JOB
    • POST A JOB
  • EDGE ADVANTAGE
    • EA Homepage
    • EA Data
  • FACILITIES
  • RESOURCES
    • PRODUCTS & SERVICES DIRECTORY
    • CALENDAR
    • CONTACT
    • ABOUT US
    • O&P LIBRARY
    • THE GUIDE
    • CUSTOM PUBLICATIONS
    • ADVERTISING INFORMATION
    • EDGE DIRECT
    • AMPLITUDE
  • OANDP-L
  • LOGIN

© 2025 The O&P EDGE

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
 

Account Activation

Before you can login, you must activate your account with the code sent to your email address. If you did not receive this email, please check your junk/spam folder. Click here to resend the activation email. If you entered an incorrect email address, you will need to re-register with the correct email address.